Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia S Bhatt, MS Pioso, EA Olesinski, B Yilma, JA Ryan, T Mashaka, B Leutz, ... Cancer cell 38 (6), 872-890. e6, 2020 | 87 | 2020 |
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs AS Sperling, M Burgess, H Keshishian, JA Gasser, S Bhatt, M Jan, ... Blood, The Journal of the American Society of Hematology 134 (2), 160-170, 2019 | 55 | 2019 |
BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia EA Olesinski, KS Bhatia, AN Mahesh, S Rosli, JS Mohamed, WY Jen, ... Blood Advances 7 (12), 2917-2923, 2023 | 4 | 2023 |
Dynamic BH3 profiling method for rapid identification of active therapy in BH3 mimetics resistant xenograft mouse models EA Olesinski, S Bhatt STAR protocols 2 (2), 100461, 2021 | 2 | 2021 |
Targeting Mitochondrial Apoptotic Priming State to Personalize Therapy for Relapsed Acute Myeloid Leukemia E Olesinski, K Bhatia, C Wang, M Pioso, SX Ng, XX Lin, V Sandhu, ... Blood 142, 48, 2023 | 1 | 2023 |
Formative evaluation prior to implementation of a brief treatment for posttraumatic stress disorder in primary care SE Valentine, C Fuchs, EA Olesinski, N Sarkisova, LB Godfrey, AR Elwy Implementation Science Communications 4 (1), 48, 2023 | 1 | 2023 |
Assessment of a Novel Program Highlighting Student Stories in Pre-Clinical Medical Curriculum at an Academic Institution EA Olesinski, S Bergenholtz, D Y, AE Hirsch Society of General Internal Medicine Annual Meeting, 2024 | | 2024 |
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts EA Olesinski, KS Bhatia, C Wang, MS Pioso, XX Lin, AM Mamdouh, ... Blood Cancer Discovery 5 (3), 180-201, 2024 | | 2024 |
A Case of Steroid-Responsive Cerebral Amyloid Angiopathy-Related Inflammation T Felong, A Bakhtyari, E Olesinski, S Lenio, A Marks 10th Annual Carlos S. Kase Boston University Neurology Research Symposium, 2024 | | 2024 |
Development and assessment of a multi-purpose knowledge-based planning model (Rapidplan) for prostate radiation X Zhang, EA Olesinski, Q Duong, MT Truong, S Lee, S Jang, K Mak, ... American Society for Radiation Oncology 117 (2), E497, 2023 | | 2023 |
Validation of a newly-developed knowledge-based model for prostate cancer radiotherapy EA Olesinski, X Zhang, Q Duong, AE Hirsch American Society of Clinical Oncology, 2023 | | 2023 |
Implementation and assessment of a novel program to highlight student stories in the BUMC pre-clinical curriculum EA Olesinski, S Bergenholtz, Y Datar, AE Hirsch Boston University Chobanian & Avedisian School of Medicine 18th Annual …, 2023 | | 2023 |
A New Achille’s Heel: Targeting Reduced Mitochondrial Apoptotic Signaling in Relapsed Acute Myeloid Leukemia EA Olesinski, KS Bhatia, MS Pioso, SX Ng, V Sandhu, B Yilma, S Bohl, ... American Medical Association Research Challenge, 2022 | | 2022 |
P310: BH3 PROFILING IDENTIFIES SELECTIVE BCL-2 DEPENDENCE OF ADULT EARLY T-CCELL PROGENITOR AND TYPICAL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS K Bhatia, A Mahesh, E Olesinski, J Garcia, N Jain, WY Jen, MOG Ming, ... HemaSphere 6, 211-212, 2022 | | 2022 |
Abstract NG14: Reduction in mitochondrial priming drives resistance to targeted therapy in acute myeloid leukemia S Bhatt, MS Piosos, EA Olesinski, BG Yilma, JA Ryan, T Mashaka, B Leutz, ... Cancer Research 81 (13_Supplement), NG14-NG14, 2021 | | 2021 |
Formative Evaluation to Identify the Need for Intervention Augmentation and System Alignment Prior to Implementation of a Brief Treatment for PTSD in Safety Net Primary Care S Valentine, C Fuchs, N Sarkisova, E Olesinski, AR Elwy International Society for Traumatic Stress Studies, 2021 | | 2021 |
Individualized Mitochondrial Functional Approach to Combination of BCL-2 and MCL-1 Antagonism in Acute Myeloid Leukemia S Bhatt, M Pioso, EA Olesinski, B Yilma, L Buon, S Adamia, H Zhu, J Ryan, ... Blood 134, 2551, 2019 | | 2019 |
Individualized functional approach to tailoring acute myeloid leukemia therapy S Bhatt, B Yilma, E Olesinski, H Zhu, M Murakami, VK Murali, S Adamia, ... Cancer Research 79 (13_Supplement), 2990-2990, 2019 | | 2019 |